TY - JOUR
T1 - Pediatric Multiple Sclerosis in the United Arab Emirates
T2 - Characteristics From a Multicenter Study and Global Comparison
AU - Ismail, Fatima Y.
AU - Gordon-Lipkin, Eliza
AU - Huether, Katherine
AU - Blair, Iain
AU - Szólics, Miklós
AU - Alsaadi, Taoufik
AU - Aziz, Faisal
AU - Suleiman, Jehan
AU - Schiess, Nicoline
N1 - Publisher Copyright:
© 2018, © The Author(s) 2018.
PY - 2018/5/1
Y1 - 2018/5/1
N2 - We delineate the clinical characteristics, incidence, and prevalence of pediatric-onset multiple sclerosis in Abu Dhabi, United Arab Emirates, from 2010 to 2014. Eighty-two patients (65% female) were identified. Fifty-three (64.6%) were Emiratis (45 from Abu Dhabi and 8 from 5 other emirates) and 29 were expatriates. Mean age of onset was 15.9 years overall, 15.3 years in males and 16.3 years in females. Patients with onset before age 12 years presented with visual symptoms while those with onset after age 12 years presented with a mixture of visual, motor and sensory symptoms. Interferon beta-1a was the most frequently used disease-modifying therapy (48%). In Abu Dhabi Emirati nationals, the age- and sex-adjusted prevalences were 26/100 000 for males and 36/100 000 for females. The total incidence in Emirati nationals from 2010 to 2014 was 2.3/100 000 for ages 10 to 14 years and 7.2/100 000 for ages 15 to 19 years. By comparison with international cohorts, the incidence of pediatric-onset multiple sclerosis in Abu Dhabi is higher whereas gender distribution is similar.
AB - We delineate the clinical characteristics, incidence, and prevalence of pediatric-onset multiple sclerosis in Abu Dhabi, United Arab Emirates, from 2010 to 2014. Eighty-two patients (65% female) were identified. Fifty-three (64.6%) were Emiratis (45 from Abu Dhabi and 8 from 5 other emirates) and 29 were expatriates. Mean age of onset was 15.9 years overall, 15.3 years in males and 16.3 years in females. Patients with onset before age 12 years presented with visual symptoms while those with onset after age 12 years presented with a mixture of visual, motor and sensory symptoms. Interferon beta-1a was the most frequently used disease-modifying therapy (48%). In Abu Dhabi Emirati nationals, the age- and sex-adjusted prevalences were 26/100 000 for males and 36/100 000 for females. The total incidence in Emirati nationals from 2010 to 2014 was 2.3/100 000 for ages 10 to 14 years and 7.2/100 000 for ages 15 to 19 years. By comparison with international cohorts, the incidence of pediatric-onset multiple sclerosis in Abu Dhabi is higher whereas gender distribution is similar.
KW - children
KW - epidemiology
KW - multiple sclerosis
KW - pediatrics
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85045055227&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045055227&partnerID=8YFLogxK
U2 - 10.1177/0883073818759103
DO - 10.1177/0883073818759103
M3 - Article
C2 - 29607711
AN - SCOPUS:85045055227
SN - 0883-0738
VL - 33
SP - 422
EP - 427
JO - Journal of Child Neurology
JF - Journal of Child Neurology
IS - 6
ER -